Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 2
2020 7
2021 2
2022 3
2023 3
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Potential therapeutics for effort-related motivational dysfunction: assessing novel atypical dopamine transport inhibitors.
Ecevitoglu A, Meka N, Rotolo RA, Edelstein GA, Srinath S, Beard KR, Carratala-Ros C, Presby RE, Cao J, Okorom A, Newman AH, Correa M, Salamone JD. Ecevitoglu A, et al. Among authors: presby re. Neuropsychopharmacology. 2024 Jul;49(8):1309-1317. doi: 10.1038/s41386-024-01826-1. Epub 2024 Mar 1. Neuropsychopharmacology. 2024. PMID: 38429498 Free PMC article.
Effort-related motivational effects of methylphenidate: Reversal of the low-effort bias induced by tetrabenazine and enhancement of progressive ratio responding in male and female rats.
Ecevitoglu A, Rotolo RA, Edelstein GA, Goldhamer A, Mitola M, Presby RE, Yu A, Pietrorazio D, Zorda E, Correa M, Salamone JD. Ecevitoglu A, et al. Among authors: presby re. Neuropharmacology. 2025 May 15;269:110345. doi: 10.1016/j.neuropharm.2025.110345. Epub 2025 Feb 8. Neuropharmacology. 2025. PMID: 39929290
Human and mouse essentiality screens as a resource for disease gene discovery.
Cacheiro P, Muñoz-Fuentes V, Murray SA, Dickinson ME, Bucan M, Nutter LMJ, Peterson KA, Haselimashhadi H, Flenniken AM, Morgan H, Westerberg H, Konopka T, Hsu CW, Christiansen A, Lanza DG, Beaudet AL, Heaney JD, Fuchs H, Gailus-Durner V, Sorg T, Prochazka J, Novosadova V, Lelliott CJ, Wardle-Jones H, Wells S, Teboul L, Cater H, Stewart M, Hough T, Wurst W, Sedlacek R, Adams DJ, Seavitt JR, Tocchini-Valentini G, Mammano F, Braun RE, McKerlie C, Herault Y, de Angelis MH, Mallon AM, Lloyd KCK, Brown SDM, Parkinson H, Meehan TF, Smedley D; Genomics England Research Consortium; International Mouse Phenotyping Consortium. Cacheiro P, et al. Nat Commun. 2020 Jan 31;11(1):655. doi: 10.1038/s41467-020-14284-2. Nat Commun. 2020. PMID: 32005800 Free PMC article.
Effects of the atypical antipsychotic and D3/D2 dopamine partial agonist cariprazine on effort-based choice behavior: implications for modeling avolition.
Ecevitoglu A, Edelstein GA, Presby RE, Rotolo RA, Yang JH, Quiles T, Okifo K, Conrad RT, Kovach A, Correa M, Salamone JD. Ecevitoglu A, et al. Among authors: presby re. Psychopharmacology (Berl). 2023 Aug;240(8):1747-1757. doi: 10.1007/s00213-023-06405-8. Epub 2023 Jun 26. Psychopharmacology (Berl). 2023. PMID: 37358806
Effort-related effects of chronic administration of the DA D2 receptor antagonist haloperidol via subcutaneous programmable minipumps: Reversal by co-administration of the adenosine A2A antagonist istradefylline.
Rotolo RA, Ecevitoglu A, Presby RE, Lindgren H, Mombereau C, Nicholas C, Moore A, Edelstein GA, Correa M, Salamone JD. Rotolo RA, et al. Among authors: presby re. Psychopharmacology (Berl). 2023 Oct;240(10):2173-2185. doi: 10.1007/s00213-023-06439-y. Epub 2023 Aug 24. Psychopharmacology (Berl). 2023. PMID: 37615683
18 results